The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Ro
The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom. (Euronews)